why choose us

First received: November 01, 2023

Clinical Trial: Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neurofibromatosis 1

Study Type: INTERVENTIONAL


Official Title: Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Brief Summary: This study will evaluate the tolerability and effectiveness of two treatments in Neurofibromatosis Type 1 Cutaneous Neurofibromas.These treatments are: Kybella and Asclera injection.Each patient will have a treatment and a control site.

Read more